Status:
COMPLETED
Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial
Lead Sponsor:
Yifeng Yu
Conditions:
Recurrent Pterygium
Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To observe the effect of micro-conjunctival autografting combined with amniotic membrane transplantation on the postoperative recurrence, complications and ocular surface symptoms among patients with ...
Detailed Description
Recurrent pterygium is a common postoperative complication of pterygium surgery, the postoperative recurrence rate is about 1.44% and needs careful treatment. At present, surgical is the main and most...
Eligibility Criteria
Inclusion
- age⩾18;
- relapsed after pterygium surgery once;
- invading the cornea 2.00\~5.00mm.
Exclusion
- having obvious severe systemic organic diseases and mental diseases;
- In lactation or pregnancy or planned pregnancy;
- combined with eye diseases such as severe eyelid insufficiency, dry eye, chemical injury of cornea and conjunctiva, etc.;
- used drugs that may affect the growth and metabolism of corneal epithelium within four weeks before inclusion in the study;
- received pterygium surgery twice or more.
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05362253
Start Date
March 1 2021
End Date
December 10 2021
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
the Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China, 330000